Authors:
de Kleijn, E
van Eijndhoven, L
Vermont, C
Kuipers, B
van Dijken, H
Rumke, H
de Groot, R
van Alphen, L
van den Dobbelsteen, G
Citation: E. De Kleijn et al., Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesiclevaccine, VACCINE, 20(3-4), 2001, pp. 352-358
Authors:
Stittelaar, KJ
Boes, J
Kersten, GFA
Speikstra, A
Mulder, PGH
de Vries, P
Roholl, PJM
Dalsgaard, K
van den Dobbelsteen, G
van Alphen, L
Osterhaus, ADME
Citation: Kj. Stittelaar et al., In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components, VACCINE, 18(23), 2000, pp. 2482-2493
Authors:
de Kleijn, ED
de Groot, R
Labadie, J
Lafeber, AB
van den Dobbelsteen, G
van Alphen, L
van Dijken, H
Kuipers, B
van Omme, GW
Wala, M
Juttmann, R
Rumke, HC
Citation: Ed. De Kleijn et al., Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age, VACCINE, 18(15), 2000, pp. 1456-1466
Authors:
van der Voort, ER
Schuller, M
Holst, J
de Vries, P
van der Ley, P
van den Dobbelsteen, G
Poolman, J
Citation: Er. Van Der Voort et al., Immunogenicity studies with a genetically engineered hexavalent PorA and awild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys, VACCINE, 18(14), 2000, pp. 1334-1343